Sampled asked Bridge Informatics’ CEO, Dan Ryder, to be their first external speaker in their popular Tech Talk video series. Talking about the reproducibility crisis commonly seen in science, Dan highlights how sample integrity coupled with data analysis can hold the answer.
After watching the Sampled Tech Talk below, click here to view the blog we wrote with Sampled that explores how to streamline research with biobanking and bioinformatics.
Dan Ryder, MPH, PhD
Dan is the founder and CEO of Bridge Informatics, a professional services firm helping pharmaceutical companies translate genomic data into medicine. Unlike any other data analytics firm, Bridge forges sustainable communication change between their client’s biological and computational scientists. Dan is particularly passionate about improving communication between people of different scientific backgrounds, enabling bioinformaticians and software engineers to collectively succeed.
Prior to forming Bridge Informatics, Dan served in a variety of roles helping pharmaceutical clients solve early-phase drug discovery and development challenges.
Dan received both a Ph.D. in Biochemistry and Molecular Biology and an MPH in Disease Control from the University of Texas Health Science Center at Houston (UTHealth Houston). He completed his postdoctoral studies in Molecular Pathways of Energy Metabolism at the University of Florida College of Medicine. Dan received his undergraduate degree in Microbiology from the University of Texas at Austin.
